The effect of monomeric and oligomeric FLAVAnols in patients with type 2 diabetes and microalbuminuria (FLAVA-trial): a double-blind randomized controlled trial

Microalbuminuria is an early sign of vascular complications of type 2 diabetes and predicts cardiovascular disease and mortality. Monomeric and oligomeric flavanols (MOFs) are linked to improved vascular health. The aim of this study was to assess the effect of 3 months MOFs on albuminuria and endothelial function markers in patients with type 2 diabetes and microalbuminuria.

Source: Clinical Nutrition - September 24, 2021 Category: Nutrition Authors: Mardin Rashid, Adrie J.M. Verhoeven, Monique T. Mulder, Reinier Timman, Behiye Ozcan, Yvonne van Beek-Nieuwland, Lei M. Chow, Roel J.J.M. van de Laar, Willem A. Dik, Eric J.G. Sijbrands, Kirsten A. Berk Tags: Randomized Control Trials Source Type: research